Click here to close now.

SYS-CON MEDIA Authors: Aria Blog, Pat Romanski, Elizabeth White, Peter Silva, Glenn Rossman

News Feed Item

Research and Development Forecast of China Heparin Industry, 2013-2017

NEW YORK, Jan. 21, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Research and Development Forecast of China Heparin Industry, 2013-2017
http://www.reportlinker.com/p01957801/Research-and-Development-Forecast-of-China-Heparin-Industry-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Research_and_Development

Research and Development Forecast of China Heparin Industry, 2013-2017 mainly analyzes the global and domestic market status quo of heparin industry, development conditions of heparin upstream and downstream industry, the supply and demand of major products, competitive pattern and business performance of domestic major enterprises; in the meanwhile, it makes the analysis and forecast of the future development of the heparin industry, offering the decisive reference for enterprises to know and invest the heparin industry.

The global heparin API manufacturing enterprises are mainly concentrated in the China, Europe and the US; the supply volume of heparin APIs of these three regions accounts for more than 95% of the global supply volume; the supply volume of heparin AIPs in China ranks the world first and accounts for more than 50% of the global supply volume.

According to the statistics of China Customs, since 2007, the export amount of China's heparin products has been rising greatly for a fourth consecutive year; in 2011, under the affection of depressed international market and the improvement of heparin export standards, the export volume and amount of China's heparin products had the obvious decline; in the year of 2012 and 2013, the decline trend of the export volume of heparin products slowed, but the export amount still had a certain decline because of the price.

At present, China has totally 22 heparin API manufacturing enterprises that have passed the approval of China Food and Drug Administration, but there are less than 10 manufacturers that have engaged in the actual production; in addition, there are 500 to 1,000 companies of heparin crude products, which form the high domestic heparin API production concentration ratio; the production capacity is mainly concentrated in the top five manufacturing enterprises of heparin products with about 80% of market shares totally now. Hepalink has the largest market shares of about 40% in the domestic market; the other major enterprises include Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Bio-pharma Co., Ltd., Yantai Dongcheng Biochemicals Co., Ltd. and Qingdao Jiulong Biomedicine Co., Ltd., while the downstream resource are inadequate.
1. Industry Overview of Heparin
1.1 Definition and Classification
1.1.1 Definition
1.1.2 Classification
1.2 Industrial Chain

2. China's Heparin Industry Development Environment
2.1 China's Economic Development Environment
2.2 Related Policies and Standards
2.2.1 Related Policies and Regulations
2.2.2 Related Standards

3. Development Overview of China's Heparin API (Active Pharmaceutical Ingredient) Industry
3.1 Development Overview of Global Heparin Industry
3.2 Status Quo of China's Heparin API Industry
3.2.1 Market Status Quo
3.2.2 Market Supply and Demand
3.3 Imports and Exports
3.4 Competitive Pattern

4. Development Overview of China's Heparin Upstream and Downstream Industry
4.1 Upstream Industry
4.2 Downstream Industry
4.2.1 Low Molecule Weight (LMW) Heparin Preparations
4.2.2 Unfractionated Heparin Preparations

5. China's Major Heparin Manufacturing Enterprises
5.1 Shenzhen Hepalink Pharmaceutical Co., Ltd. (Hepalink)
5.1.1 Company Profile
5.1.2 Business Performance
5.1.3 Research & Development and Investment
5.1.4 Development Prospects
5.2 Changzhou Qianhong Bio-pharma Co., Ltd.

5.2.1 Company Profile
5.2.2 Business Performance
5.2.3 Research & Development and Investment
5.2.4 Development Prospects
5.3 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
5.3.1 Company Profile
5.3.2 Business Performance
5.3.3 Research & Development and Investment
5.3.4 Development Prospects
5.4 Yantai Dongcheng Biochemicals Co., Ltd.
5.4.1 Company Profile
5.4.2 Business Performance
5.4.3 Research & Development and Investment
5.4.4 Development Prospects
5.5 Tianjin Chase Sun Pharmaceutical Co., Ltd.
5.5.1 Company Profile
5.5.2 Business Performance
5.5.3 Research & Development and Investment
5.5.4 Development Prospects
5.6 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
5.6.1 Company Profile
5.6.2 Research & Development
5.6.3 Development Prospects
5.7 Qingdao Jiulong Biomedicine Co., Ltd.

6. Investment Analysis of Heparin Industry
6.1 Investment Risks
6.1.1 Industry Risk
6.1.2 Intensifying Market Competition
6.1.3 Loss of Technical Personnel
6.1.4 Downward Product Price
6.1.5 Raw Material Price Fluctuation
6.1.6 Exchange Rate Fluctuation
6.2 Investment Suggestions
6.2.1 Investing the Scale Enterprises
6.2.2 Paying Attention to Brand Building
6.2.3 Doing Well Human Resource Management
6.2.4 Developing New Products and Being Diversified
6.2.5 Competition Alliance

7. Development Trends and Forecast of Heparin Industry
7.1 Development Trends
7.2 Market Scale Forecast of Heparin Products

To order this report: Research and Development Forecast of China Heparin Industry, 2013-2017
http://www.reportlinker.com/p01957801/Research-and-Development-Forecast-of-China-Heparin-Industry-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Research_and_Development

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The explosion of connected devices / sensors is creating an ever-expanding set of new and valuable data. In parallel the emerging capability of Big Data technologies to store, access, analyze, and react to this data is producing changes in business models under the umbrella of the Internet of Things (IoT). In particular within the Insurance industry, IoT appears positioned to enable deep changes by altering relationships between insurers, distributors, and the insured. In his session at @Things...
DevOps is about increasing efficiency, but nothing is more inefficient than building the same application twice. However, this is a routine occurrence with enterprise applications that need both a rich desktop web interface and strong mobile support. With recent technological advances from Isomorphic Software and others, it is now feasible to create a rich desktop and tuned mobile experience with a single codebase, without compromising performance or usability.
SYS-CON Events announced today that Vitria Technology, Inc. will exhibit at SYS-CON’s @ThingsExpo, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Vitria will showcase the company’s new IoT Analytics Platform through live demonstrations at booth #330. Vitria’s IoT Analytics Platform, fully integrated and powered by an operational intelligence engine, enables customers to rapidly build and operationalize advanced analytics to deliver timely business outcomes ...
SYS-CON Events announced today that GENBAND, a leading developer of real time communications software solutions, has been named “Silver Sponsor” of SYS-CON's WebRTC Summit, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. The GENBAND team will be on hand to demonstrate their newest product, Kandy. Kandy is a communications Platform-as-a-Service (PaaS) that enables companies to seamlessly integrate more human communications into their Web and mobile applicatio...
VictorOps is making on-call suck less with the only collaborative alert management platform on the market. With easy on-call scheduling management, a real-time incident timeline that gives you contextual relevance around your alerts and powerful reporting features that make post-mortems more effective, VictorOps helps your IT/DevOps team solve problems faster.
The Internet of Everything (IoE) brings together people, process, data and things to make networked connections more relevant and valuable than ever before – transforming information into knowledge and knowledge into wisdom. IoE creates new capabilities, richer experiences, and unprecedented opportunities to improve business and government operations, decision making and mission support capabilities. In his session at @ThingsExpo, Gary Hall, Chief Technology Officer, Federal Defense at Cisco S...
The Internet of Things (IoT) is causing data centers to become radically decentralized and atomized within a new paradigm known as “fog computing.” To support IoT applications, such as connected cars and smart grids, data centers' core functions will be decentralized out to the network's edges and endpoints (aka “fogs”). As this trend takes hold, Big Data analytics platforms will focus on high-volume log analysis (aka “logs”) and rely heavily on cognitive-computing algorithms (aka “cogs”) to mak...
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, will discuss why containers should be paired with new architectural practices such as microservices ra...
Companies today struggle to manage the types and volume of data their customers and employees generate and use every day. With billions of requests daily, operational consistency can be elusive. In his session at Big Data Expo, Dave McCrory, CTO at Basho Technologies, will explore how a distributed systems solution, such as NoSQL, can give organizations the consistency and availability necessary to succeed with on-demand data, offering high availability at massive scale.
The speed of software changes in growing and large scale rapid-paced DevOps environments presents a challenge for continuous testing. Many organizations struggle to get this right. Practices that work for small scale continuous testing may not be sufficient as the requirements grow. In his session at DevOps Summit, Marc Hornbeek, Sr. Solutions Architect of DevOps continuous test solutions at Spirent Communications, will explain the best practices of continuous testing at high scale, which is r...
From telemedicine to smart cars, digital homes and industrial monitoring, the explosive growth of IoT has created exciting new business opportunities for real time calls and messaging. In his session at @ThingsExpo, Ivelin Ivanov, CEO and Co-Founder of Telestax, shared some of the new revenue sources that IoT created for Restcomm – the open source telephony platform from Telestax. Ivelin Ivanov is a technology entrepreneur who founded Mobicents, an Open Source VoIP Platform, to help create, de...
The industrial software market has treated data with the mentality of “collect everything now, worry about how to use it later.” We now find ourselves buried in data, with the pervasive connectivity of the (Industrial) Internet of Things only piling on more numbers. There’s too much data and not enough information. In his session at @ThingsExpo, Bob Gates, Global Marketing Director, GE’s Intelligent Platforms business, to discuss how realizing the power of IoT, software developers are now focu...
SYS-CON Media announced that IBM, which offers the world’s deepest portfolio of technologies and expertise that are transforming the future of work, has launched ad campaigns on SYS-CON’s numerous online magazines such as Cloud Computing Journal, Virtualization Journal, SOA World Magazine, and IoT Journal. IBM’s campaigns focus on vendors in the technology marketplace, the future of testing, Big Data and analytics, and mobile platforms.
Security can create serious friction for DevOps processes. We've come up with an approach to alleviate the friction and provide security value to DevOps teams. In her session at DevOps Summit, Shannon Lietz, Senior Manager of DevSecOps at Intuit, will discuss how DevSecOps got started and how it has evolved. Shannon Lietz has over two decades of experience pursuing next generation security solutions. She is currently the DevSecOps Leader for Intuit where she is responsible for setting and driv...
The explosion of connected devices / sensors is creating an ever-expanding set of new and valuable data. In parallel the emerging capability of Big Data technologies to store, access, analyze, and react to this data is producing changes in business models under the umbrella of the Internet of Things (IoT). In particular within the Insurance industry, IoT appears positioned to enable deep changes by altering relationships between insurers, distributors, and the insured. In his session at @Things...